Association between Poorer Cognitive Function and Reduced Objectively Monitored Medication Adherence in Patients with Heart Failure

Mary A. Dolansky, Misty A.W. Hawkins, Julie T. Schaefer, Abdus Sattar, John Gunstad, Joseph D. Redle, Richard Josephson, Shirley M. Moore, Joel W. Hughes

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Background - Subclinical cognitive impairment is prevalent in heart failure (HF); however, its role in important clinical outcomes, such as HF treatment adherence, is unclear. Given the complex polypharmacy in HF treatment, cognitive deficits may be important in predicting medication management. Thus, the objective of the current study was to examine the impact of cognitive function on medication adherence among community-dwelling patients with HF using objective assessments. Methods and Results - A prospective observational cohort design of 309 community-dwelling patients with HF (59.7% male, 68.7±9.7 years) and no history of dementia or neurological disease. Cognition was assessed using a neuropsychological battery at baseline. Medication adherence was objectively measured for 21 days using an electronic pillbox. Regression analyses tested whether attention, executive function, or memory predicted 21-day medication adherence. In unadjusted analyses, lower scores on all 3 cognitive domains predicted poorer medication adherence (β=0.52-85; P=0.001-0.009). After adjusting for demographic, clinical, and psychosocial variables, memory continued to predict medication adherence (β=0.51; P=0.008), whereas executive function (β=0.24; P=0.075) and attention were no longer a predictor (β=0.34; P=0.131). Conclusions - Poorer cognitive function, especially in regard to memory, predicted reduced medication adherence among patients with HF and no history of dementia. This effect remained after adjustment for factors known to predict adherence, such as depressed mood, social support, and disease severity level. Future studies should examine the link from cognitive impairment and medication nonadherence to clinical outcomes (eg, hospitalization and mortality). Clinical Trial Registration - URL: http://www.clinicaltrials.gov. Unique identifier: NCT01461629.

Original languageEnglish
Article numbere002475
JournalCirculation: Heart Failure
Volume9
Issue number12
DOIs
StatePublished - 1 Dec 2016
Externally publishedYes

Fingerprint

Medication Adherence
Cognition
Heart Failure
Independent Living
Executive Function
Dementia
Polypharmacy
Social Support
Hospitalization
Regression Analysis
Demography
Clinical Trials
Mortality
Therapeutics

Keywords

  • cognitive function
  • dementia
  • depression
  • heart failure
  • medication adherence

Cite this

Dolansky, Mary A. ; Hawkins, Misty A.W. ; Schaefer, Julie T. ; Sattar, Abdus ; Gunstad, John ; Redle, Joseph D. ; Josephson, Richard ; Moore, Shirley M. ; Hughes, Joel W. / Association between Poorer Cognitive Function and Reduced Objectively Monitored Medication Adherence in Patients with Heart Failure. In: Circulation: Heart Failure. 2016 ; Vol. 9, No. 12.
@article{e3dc20da488d4494928c0c8bc87a1a2f,
title = "Association between Poorer Cognitive Function and Reduced Objectively Monitored Medication Adherence in Patients with Heart Failure",
abstract = "Background - Subclinical cognitive impairment is prevalent in heart failure (HF); however, its role in important clinical outcomes, such as HF treatment adherence, is unclear. Given the complex polypharmacy in HF treatment, cognitive deficits may be important in predicting medication management. Thus, the objective of the current study was to examine the impact of cognitive function on medication adherence among community-dwelling patients with HF using objective assessments. Methods and Results - A prospective observational cohort design of 309 community-dwelling patients with HF (59.7{\%} male, 68.7±9.7 years) and no history of dementia or neurological disease. Cognition was assessed using a neuropsychological battery at baseline. Medication adherence was objectively measured for 21 days using an electronic pillbox. Regression analyses tested whether attention, executive function, or memory predicted 21-day medication adherence. In unadjusted analyses, lower scores on all 3 cognitive domains predicted poorer medication adherence (β=0.52-85; P=0.001-0.009). After adjusting for demographic, clinical, and psychosocial variables, memory continued to predict medication adherence (β=0.51; P=0.008), whereas executive function (β=0.24; P=0.075) and attention were no longer a predictor (β=0.34; P=0.131). Conclusions - Poorer cognitive function, especially in regard to memory, predicted reduced medication adherence among patients with HF and no history of dementia. This effect remained after adjustment for factors known to predict adherence, such as depressed mood, social support, and disease severity level. Future studies should examine the link from cognitive impairment and medication nonadherence to clinical outcomes (eg, hospitalization and mortality). Clinical Trial Registration - URL: http://www.clinicaltrials.gov. Unique identifier: NCT01461629.",
keywords = "cognitive function, dementia, depression, heart failure, medication adherence",
author = "Dolansky, {Mary A.} and Hawkins, {Misty A.W.} and Schaefer, {Julie T.} and Abdus Sattar and John Gunstad and Redle, {Joseph D.} and Richard Josephson and Moore, {Shirley M.} and Hughes, {Joel W.}",
year = "2016",
month = "12",
day = "1",
doi = "10.1161/CIRCHEARTFAILURE.116.002475",
language = "English",
volume = "9",
journal = "Circulation: Heart Failure",
issn = "1941-3289",
publisher = "Lippincott Williams and Wilkins Ltd.",
number = "12",

}

Association between Poorer Cognitive Function and Reduced Objectively Monitored Medication Adherence in Patients with Heart Failure. / Dolansky, Mary A.; Hawkins, Misty A.W.; Schaefer, Julie T.; Sattar, Abdus; Gunstad, John; Redle, Joseph D.; Josephson, Richard; Moore, Shirley M.; Hughes, Joel W.

In: Circulation: Heart Failure, Vol. 9, No. 12, e002475, 01.12.2016.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Association between Poorer Cognitive Function and Reduced Objectively Monitored Medication Adherence in Patients with Heart Failure

AU - Dolansky, Mary A.

AU - Hawkins, Misty A.W.

AU - Schaefer, Julie T.

AU - Sattar, Abdus

AU - Gunstad, John

AU - Redle, Joseph D.

AU - Josephson, Richard

AU - Moore, Shirley M.

AU - Hughes, Joel W.

PY - 2016/12/1

Y1 - 2016/12/1

N2 - Background - Subclinical cognitive impairment is prevalent in heart failure (HF); however, its role in important clinical outcomes, such as HF treatment adherence, is unclear. Given the complex polypharmacy in HF treatment, cognitive deficits may be important in predicting medication management. Thus, the objective of the current study was to examine the impact of cognitive function on medication adherence among community-dwelling patients with HF using objective assessments. Methods and Results - A prospective observational cohort design of 309 community-dwelling patients with HF (59.7% male, 68.7±9.7 years) and no history of dementia or neurological disease. Cognition was assessed using a neuropsychological battery at baseline. Medication adherence was objectively measured for 21 days using an electronic pillbox. Regression analyses tested whether attention, executive function, or memory predicted 21-day medication adherence. In unadjusted analyses, lower scores on all 3 cognitive domains predicted poorer medication adherence (β=0.52-85; P=0.001-0.009). After adjusting for demographic, clinical, and psychosocial variables, memory continued to predict medication adherence (β=0.51; P=0.008), whereas executive function (β=0.24; P=0.075) and attention were no longer a predictor (β=0.34; P=0.131). Conclusions - Poorer cognitive function, especially in regard to memory, predicted reduced medication adherence among patients with HF and no history of dementia. This effect remained after adjustment for factors known to predict adherence, such as depressed mood, social support, and disease severity level. Future studies should examine the link from cognitive impairment and medication nonadherence to clinical outcomes (eg, hospitalization and mortality). Clinical Trial Registration - URL: http://www.clinicaltrials.gov. Unique identifier: NCT01461629.

AB - Background - Subclinical cognitive impairment is prevalent in heart failure (HF); however, its role in important clinical outcomes, such as HF treatment adherence, is unclear. Given the complex polypharmacy in HF treatment, cognitive deficits may be important in predicting medication management. Thus, the objective of the current study was to examine the impact of cognitive function on medication adherence among community-dwelling patients with HF using objective assessments. Methods and Results - A prospective observational cohort design of 309 community-dwelling patients with HF (59.7% male, 68.7±9.7 years) and no history of dementia or neurological disease. Cognition was assessed using a neuropsychological battery at baseline. Medication adherence was objectively measured for 21 days using an electronic pillbox. Regression analyses tested whether attention, executive function, or memory predicted 21-day medication adherence. In unadjusted analyses, lower scores on all 3 cognitive domains predicted poorer medication adherence (β=0.52-85; P=0.001-0.009). After adjusting for demographic, clinical, and psychosocial variables, memory continued to predict medication adherence (β=0.51; P=0.008), whereas executive function (β=0.24; P=0.075) and attention were no longer a predictor (β=0.34; P=0.131). Conclusions - Poorer cognitive function, especially in regard to memory, predicted reduced medication adherence among patients with HF and no history of dementia. This effect remained after adjustment for factors known to predict adherence, such as depressed mood, social support, and disease severity level. Future studies should examine the link from cognitive impairment and medication nonadherence to clinical outcomes (eg, hospitalization and mortality). Clinical Trial Registration - URL: http://www.clinicaltrials.gov. Unique identifier: NCT01461629.

KW - cognitive function

KW - dementia

KW - depression

KW - heart failure

KW - medication adherence

UR - http://www.scopus.com/inward/record.url?scp=85006857913&partnerID=8YFLogxK

U2 - 10.1161/CIRCHEARTFAILURE.116.002475

DO - 10.1161/CIRCHEARTFAILURE.116.002475

M3 - Article

C2 - 27895069

AN - SCOPUS:85006857913

VL - 9

JO - Circulation: Heart Failure

JF - Circulation: Heart Failure

SN - 1941-3289

IS - 12

M1 - e002475

ER -